Z Gastroenterol 2018; 56(10): 1276-1282
DOI: 10.1055/a-0645-7169
Übersicht
© Georg Thieme Verlag KG Stuttgart · New York

Die Acid Pocket: ein neues Ziel für die Behandlung der gastroösophagealen Refluxkrankheit

The acid pocket – a novel target for the treatment of gastro-esophageal reflux disease
Matthias Sauter
1   Bauchzentrum, Abteilung für Gastroenterologie, St. Claraspital, Basel, Schweiz
2   Klinik für Gastroenterologie und Hepatologie, UniversitätsSpital Zürich, Switzerland
,
Mark Robert Fox
1   Bauchzentrum, Abteilung für Gastroenterologie, St. Claraspital, Basel, Schweiz
2   Klinik für Gastroenterologie und Hepatologie, UniversitätsSpital Zürich, Switzerland
› Author Affiliations
Further Information

Publication History

22 January 2018

14 June 2018

Publication Date:
10 October 2018 (online)

Zusammenfassung

Die gastroösophageale Refluxkrankheit stellt die häufigste Ursache für Symptome des oberen Gastrointestinaltrakts dar.

Der Säure-Reflux in der postprandialen Phase ist der prädominante Faktor der gastroösophagealen Refluxkrankheit (gastro-esophageal Reflux disease, GERD) und führt zu Beschwerden wie Sodbrennen und saurem Aufstoßen. Die chronische Säureexposition des Ösophagus führt zudem zu Komplikationen wie der Refluxösophagitis, peptischen Stenosen, dem Barrett-Ösophagus oder dem Adenokarzinom.

Das Ausmaß an mukosalen Schäden und Symptomen hängt von zwei Hauptfaktoren ab: (1.) dem Säuregehalt des Refluxats, welches primär von der gastralen Säureproduktion und der Verteilung der Säure im Magen abhängt sowie (2.) der Häufigkeit / Dauer an Refluxepisoden und der Stärke der Refluxbarriere am gastroösophagealen Übergang. Das Konzept der Acid Pocket ist ein Versuch, diese Faktoren in einem gemeinsamen Pathomechanismus zu vereinen.

Die Acid Pocket beschreibt eine Ansammlung von Magensäure am gastroösophagealen Übergang in der postprandialen Phase und stellt ein wichtiges Reservoir für gastroösophageale Refluxepisoden dar. Die Acid Pocket ist sowohl bei Gesunden wie auch bei Refluxpatienten vorhanden. Insbesondere bei Patienten mit einer Hiatushernie und / oder einem hypotensiven unteren Ösophagus-Sphinkter kann sich die Acid Pocket aber über den gastroösophagealen Übergang hinaus in den distalen Ösophagus ausbreiten, was zu einer erhöhten Säureexposition insbesondere des distalsten Ösophagus-Abschnitts und somit Refluxbeschwerden führt.

In den letzten Jahren wurde die Acid Pocket als mögliches Ziel von pharmakologischen und chirurgischen GERD-Therapien postuliert. Säurehemmende Medikamente wie z. B. Protonen-Pumpen-Inhibitoren reduzieren den Säuregehalt der Acid Pocket, wogegen Alginat-Substanzen, Prokinetika und die Fundoplikatio-Operation die Acid Pocket nach distal weg vom gastroösophagealen Übergang dislozieren.

Abstract

Increased acid reflux after meals is a key feature of gastro-esophageal reflux disease (GERD) and is the most important cause for patient symptoms, particularly heartburn and acid regurgitation. Chronic acid exposure also predisposes to associated pathologies including reflux esophagitis, esophageal stricture, Barrett’s esophagus, and Barrett’s carcinoma (esophageal adenocarcinoma). The severity of esophageal symptoms and mucosal damage is related to two key factors, (i) the acidity of the refluxate, which depends primarily on the gastric secretory output and its distribution within the stomach, and (ii) the frequency and duration of reflux events which depends on the efficacy of the reflux barrier at the gastro-esophageal junction and the esophageal clearance function. The concept of the acid pocket is an attempt to bring these two factors into a unified patho-mechanism.

The acid pocket describes an area of unbuffered, highly acidic, gastric secretion in the proximal stomach adjacent to the esophago-gastric junction (GEJ) which forms in the postprandial period and is the source of acid refluxate into the esophagus. It is observed both in healthy individuals as well as in reflux patients. However, the presence of a hiatus hernia and/or a weak lower esophageal sphincter in patients allows the acid pocket to encroach on the gastro-esophageal junction. This results in very high acid exposure of the squamous epithelium of the distal esophagus, leading to mucosal damage and symptoms. Recently, the acid pocket has been proposed as a target for pharmacological and surgical therapies of GERD. Proton pump inhibitors and related medications reduce its acidity; whereas, alginate preparations, prokinetics, and fundoplication displace it away from the gastro-esophageal junction.

 
  • Literatur

  • 1 Vakil N, van Zanten SV, Kahrilas P. et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900-1920
  • 2 Haag S, Andrews JM, Gapasin J. et al. A 13-nation population survey of upper gastrointestinal symptoms: prevalence of symptoms and socioeconomic factors. Aliment Pharmacol Ther 2011; 33: 722-729
  • 3 El-Serag HB, Sweet S, Winchester CC. et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2014; 63: 871-880
  • 4 Anderson P, Dalziel K, Davies E. et al. Survey of digestive health across Europe: Final report. Part 2: The economic impact and burden of digestive disorders. United European Gastroenterol J 2014; 2: 544-546
  • 5 Darba J, Kaskens L, Plans P. et al. Epidemiology and societal costs of gastroesophageal reflux disease and Barrett's syndrome in Germany, Italy and Spain. Expert Rev Pharmacoecon Outcomes Res 2011; 11: 225-232
  • 6 Savarino E, Tutuian R, Zentilin P. et al. Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy. Am J Gastroenterol 2010; 105: 1053-1061
  • 7 Steingoetter A, Sauter M, Curcic J. et al. Volume, distribution and acidity of gastric secretion on and off proton pump inhibitor treatment: a randomized double-blind controlled study in patients with gastro-esophageal reflux disease (GERD) and healthy subjects. BMC Gastroenterol 2015; 15: 111
  • 8 Fisher RS, Sher DJ, Donahue D. et al. Regional differences in gastric acidity and antacid distribution: is a single pH electrode sufficient?. Am J Gastroenterol 1997; 92: 263-270
  • 9 Goetze O, Treier R, Fox M. et al. The effect of gastric secretion on gastric physiology and emptying in the fasted and fed state assessed by magnetic resonance imaging. Neurogastroenterol Motil 2009; 21: 725-742
  • 10 Fletcher J, Wirz A, Young J. et al. Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroenterology 2001; 121: 775-783
  • 11 Mason RJ, Oberg S, Bremner CG. et al. Postprandial gastroesophageal reflux in normal volunteers and symptomatic patients. J Gastrointest Surg 1998; 2: 342-349
  • 12 Beaumont H, Bennink RJ, de Jong J. et al. The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GORD. Gut 2010; 59: 441-451
  • 13 Clarke AT, Wirz AA, Manning JJ. et al. Severe reflux disease is associated with an enlarged unbuffered proximal gastric acid pocket. Gut. [Research Support, Non-U. S. Gov’t] 2008; 57: 292-297
  • 14 Clarke AT, Wirz AA, Seenan JP. et al. Paradox of gastric cardia: it becomes more acidic following meals while the rest of stomach becomes less acidic. Gut 2009; 58: 904-909
  • 15 Pandolfino JE, Zhang Q, Ghosh SK. et al. Acidity surrounding the squamocolumnar junction in GERD patients: “acid pocket” versus “acid film”. Am J Gastroenterol [Research Support, N. I. H., Extramural Research Support, Non-U. S. Gov’t] 2007; 102: 2633-2641
  • 16 Hila A, Bouali H, Xue S. et al. Postprandial stomach contents have multiple acid layers. J Clin Gastroenterol 2006; 40: 612-617
  • 17 Kuiken S, Van Den Elzen B, Tytgat G. et al. Evidence for pooling of gastric secretions in the proximal stomach in humans using single photon computed tomography. Gastroenterology 2002; 123: 2157-2158
  • 18 Sauter M, Curcic J, Menne D. et al. Measuring the interaction of meal and gastric secretion: a combined quantitative magnetic resonance imaging and pharmacokinetic modeling approach. Neurogastroenterol Motil 2012; 24: 632-638
  • 19 Boeckxstaens GE. Alterations confined to the gastro-oesophageal junction: the relationship between low LOSP, TLOSRs, hiatus hernia and acid pocket. Best Pract Res Clin Gastroenterol 2010; 24: 821-829
  • 20 Indireshkumar K, Brasseur JG, Faas H. et al. Relative contributions of “pressure pump” and “peristaltic pump” to gastric emptying. Am J Physiol Gastrointest Liver Physiol 2000; 278: G604-G616
  • 21 Kwiatek MA, Fox MR, Steingoetter A. et al. Effects of clonidine and sumatriptan on postprandial gastric volume response, antral contraction waves and emptying: an MRI study. Neurogastroenterol Motil 2009; 21: 928 – e71
  • 22 Loewenstein MS. Physiology of the gastrointestinal tract. Edited by Leonard R. Johnson. 1,492 pp. New York: Raven Press, 1981. Hepatology 1982; 2: 891
  • 23 Meyer JH, Dressman J, Fink A. et al. Effect of size and density on canine gastric emptying of nondigestible solids. Gastroenterology 1985; 89: 805-813
  • 24 Brown BP, Schulze DelrieuK, Schrier JE. et al. The configuration of the human gastroduodenal junction in the separate emptying of liquids and solids. Gastroenterology 1993; 105: 433-440
  • 25 Simonian HP, Vo L, Doma S. et al. Regional postprandial differences in pH within the stomach and gastroesophageal junction. Dig Dis Sci 2005; 50: 2276-2285
  • 26 Grigolon A, Cantu P, Bravi I. et al. Subcardial 24-h wireless pH monitoring in gastroesophageal reflux disease patients with and without hiatal hernia compared with healthy subjects. Am J Gastroenterol 2009; 104: 2714-2720
  • 27 Rohof WO, Bennink RJ, Boeckxstaens GE. Proton pump inhibitors reduce the size and acidity of the acid pocket in the stomach. Clin Gastroenterol Hepatol 2014; 12: 1101-1107
  • 28 Rohof WO, Bennink RJ, de Jonge H. et al. Increased proximal reflux in a hypersensitive esophagus might explain symptoms resistant to proton pump inhibitors in patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2014; 12: 1647-1655
  • 29 Shaker R, Dodds WJ, Kahrilas PJ. et al. Relationship of intraluminal pH and pressure within the lower esophageal sphincter. Am J Gastroenterol 1991; 86: 812-816
  • 30 Pandolfino JE, El-Serag HB, Zhang Q. et al. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology 2006; 130: 639-649
  • 31 Mekapati J, Knight LC, Maurer AH. et al. Transsphincteric pH profile at the gastroesophageal junction. Clin Gastroenterol Hepatol 2008; 6: 630-634
  • 32 Fletcher J, Wirz A, Henry E. et al. Studies of acid exposure immediately above the gastro-oesophageal squamocolumnar junction: evidence of short segment reflux. Gut 2004; 53: 168-173
  • 33 Bredenoord AJ, Weusten BL, Timmer R. et al. Intermittent spatial separation of diaphragm and lower esophageal sphincter favors acidic and weakly acidic reflux. Gastroenterology 2006; 130: 334-340
  • 34 Boeckxstaens G, El-Serag HB, Smout AJ. et al. Symptomatic reflux disease: the present, the past and the future. Gut 2014; 63: 1185-1193
  • 35 McQuaid KR, Laine L, Fennerty MB. et al. Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia. Aliment Pharmacol Ther 2011; 34: 146-165
  • 36 Sifrim D, Holloway R. Transient lower esophageal sphincter relaxations: how many or how harmful?. Am J Gastroenterol 2001; 96: 2529-2532
  • 37 Trudgill NJ, Riley SA. Transient lower esophageal sphincter relaxations are no more frequent in patients with gastroesophageal reflux disease than in asymptomatic volunteers. Am J Gastroenterol 2001; 96: 2569-2574
  • 38 Curcic J, Fox M, Kaufman E. et al. Gastroesophageal junction: structure and function as assessed by using MR imaging. Radiology 2010; 257: 115-124
  • 39 Curcic J, Schwizer A, Kaufman E. et al. Effects of baclofen on the functional anatomy of the oesophago-gastric junction and proximal stomach in healthy volunteers and patients with GERD assessed by magnetic resonance imaging and high-resolution manometry: a randomised controlled double-blind study. Aliment Pharmacol Ther 2014; 40: 1230-1240
  • 40 Kahrilas PJ, Dodds WJ, Hogan WJ. et al. Esophageal peristaltic dysfunction in peptic esophagitis. Gastroenterology 1986; 91: 897-904
  • 41 Daum C, Sweis R, Kaufman E. et al. Failure to respond to physiologic challenge characterizes esophageal motility in erosive gastro-esophageal reflux disease. Neurogastroenterol Motil 2011; 23: 517 – e200
  • 42 Kahrilas PJ, Dodds WJ, Hogan WJ. Effect of peristaltic dysfunction on esophageal volume clearance. Gastroenterology 1988; 94: 73-80
  • 43 Kahrilas PJ, Lin S, Chen J. et al. The effect of hiatus hernia on gastro-oesophageal junction pressure. Gut 1999; 44: 476-482
  • 44 Curcic J, Roy S, Schwizer A. et al. Abnormal structure and function of the esophagogastric junction and proximal stomach in gastroesophageal reflux disease. Am J Gastroenterol 2014; 109: 658-667
  • 45 Boecxstaens V, Bisschops R, Blondeau K. et al. Modulation of the postprandial acid and bile pockets at the gastro-oesophageal junction by drugs that affect gastric motility. Aliment Pharmacol Ther 2011; 33: 1370-1377
  • 46 Rohof WO, Bennink RJ, de Ruigh AA. et al. Effect of azithromycin on acid reflux, hiatus hernia and proximal acid pocket in the postprandial period. Gut 2012; 61: 1670-1767
  • 47 Scarpellini E, Boecxstaens V, Broers C. et al. Effect of baclofen on gastric acid pocket in subjects with gastroesophageal reflux disease symptoms. Dis Esophagus 2016; 29: 1054-1063
  • 48 Scarpellini E, Boecxstaens V, Farre R. et al. Effect of baclofen on the acid pocket at the gastroesophageal junction. Dis Esophagus 2015; 28: 488-495
  • 49 Morgan D, Pandolfino J, Katz PO. et al. Clinical trial: gastric acid suppression in Hispanic adults with symptomatic gastro-oesophageal reflux disease - comparator study of esomeprazole, lansoprazole and pantoprazole. Aliment Pharmacol Ther 2010; 32: 200-208
  • 50 Vo L, Simonian HP, Doma S. et al. The effect of rabeprazole on regional gastric acidity and the postprandial cardia/gastro-oesophageal junction acid layer in normal subjects: a randomized, double-blind, placebo-controlled study. Aliment Pharmacol Ther 2005; 21: 1321-1330
  • 51 Zentilin P, Dulbecco P, Savarino E. et al. An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH-metry. Aliment Pharmacol Ther 2005; 21: 29-34
  • 52 Sweis R, Kaufman E, Anggiansah A. et al. Post-prandial reflux suppression by a raft-forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH-impedance monitoring: mechanistic assessment in healthy volunteers and randomised, controlled, double-blind study in reflux patients. Aliment Pharmacol Ther 2013; 37: 1093-1102
  • 53 Corvaglia L, Spizzichino M, Zama D. et al. Sodium Alginate (Gaviscon(R)) does not reduce apnoeas related to gastro-oesophageal reflux in preterm infants. Early Hum Dev 2011; 87: 775-778
  • 54 Atasay B, Erdeve O, Arsan S. et al. Effect of sodium alginate on acid gastroesophageal reflux disease in preterm infants: a pilot study. J Clin Pharmacol 2010; 50: 1267-1272
  • 55 Kwiatek MA, Roman S, Fareeduddin A. et al. An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial “acid pocket” in symptomatic GERD patients. Aliment Pharmacol Ther 2011; 34: 59-66
  • 56 Rohof WO, Bennink RJ, Smout AJ. et al. An alginate-antacid formulation localizes to the acid pocket to reduce acid reflux in patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2013; 11: 1585-1591
  • 57 De Ruigh A, Roman S, Chen J. et al. Gaviscon Double Action Liquid (antacid & alginate) is more effective than antacid in controlling post-prandial oesophageal acid exposure in GERD patients: a double-blind crossover study. Aliment Pharmacol Ther 2014; 40: 531-537
  • 58 Leiman DA, Riff BP, Morgan S. et al. Alginate therapy is effective treatment for gastroesophageal reflux disease symptoms: a systematic review and meta-analysis. Dis Esophagus 2017; 30: 1-8
  • 59 Manabe N, Haruma K, Ito M. et al. Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: a randomized clinical trial. Dis Esophagus 2012; 25: 373-380
  • 60 Herbella FA, Vicentine FP, Silva LC. et al. Postprandial proximal gastric acid pocket and gastroesophageal reflux disease. Dis Esophagus 2012; 25: 652-655
  • 61 Herbella FA, Vicentine FP, Silva LC. et al. Postprandial proximal gastric acid pocket in patients after distal gastrectomy. Neurogastroenterol Motil 2011; 23: 1081-1083
  • 62 Herbella FA, Vicentine FP, Del GrandeJC. et al. Postprandial proximal gastric acid pocket in patients after laparoscopic Nissen fundoplication. Surg Endosc 2011; 25: 3198-3201
  • 63 Herbella FA, Vicentine FP, Del GrandeJC. et al. Postprandial proximal gastric acid pocket and gastric pressure in patients after gastric surgery. Neurogastroenterol Motil 2011; 23: 52-55
  • 64 Herbella FA, Vicentine FP, Del GrandeJC. et al. Postprandial proximal gastric acid pocket in patients after Roux-en-Y gastric bypass. J Gastrointest Surg 2010; 14: 1742-1745